Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab
Blood Research
; : 137-138, 2016.
Article
in En
| WPRIM
| ID: wpr-203292
Responsible library:
WPRO
ABSTRACT
No abstract available.
Full text:
1
Index:
WPRIM
Main subject:
Red-Cell Aplasia, Pure
/
Rituximab
Language:
En
Journal:
Blood Research
Year:
2016
Type:
Article